Optimizing Clinical Trials in China with Strategic Solutions for Supply Chain Challenges
Summary: China continues to be a key player in global clinical trials, offering vast opportunities for pharmaceutical innovation. However, navigating its rapidly evolving regulatory landscape and complex logistics requires strategic supply chain planning. Catalent provides tailored solutions to address these challenges, leveraging Free Trade Zones (FTZs) for streamlined customs processes, ensuring temperature-controlled transport across diverse climates, and offering expert in-country comparator sourcing. By optimizing clinical supply strategies, Catalent empowers sponsors to efficiently conduct trials in China while maintaining compliance, product integrity, and operational efficiency.
Download the full article to explore how Catalent’s innovative supply chain strategies can help you successfully manage clinical trials in China.